UBS Group AG

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in OTLK

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$27,411

-$303,660 QoQ

Shares Held

133,069

-36.5% QoQ

Ownership

0.110%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 54 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. OTLK ranks #416 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,411	133,069	-36.5%	Shares	Defined	2026-05-05
2025-12-31	$331,071	209,540	+335.5%	Shares	Defined	2026-01-29
2025-09-30	$50,999	48,114	-12.7%	Shares	Defined	2025-11-13
2025-06-30	$88,197	55,124	-41.7%	Shares	Defined	2025-08-14
2025-03-31	$115,414	94,603	-67.0%	Shares	Defined	2025-05-13
2024-12-31	$541,757	286,644	+3905.6%	Shares	Defined	2025-02-14
2024-09-30	$38,213	7,156	+196.9%	Shares	Sole	2024-11-14
2024-06-30	$17,785	2,410	-74.1%	Shares	Sole	2024-08-14
2024-03-31	$111,316	9,323	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.